A phase II trial of methotrexate-human serum albumine ( MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy

AN (André) Vis; Ate van der Gaast; BWG (Bas) van Rhijn; T Catsburg - Wittebol; C Schmidt; GHJ Mickisch

doi:10.1007/s00280-001-0417-z

A phase II trial of methotrexate-human serum albumine ( MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy

AN (André) Vis, Ate van der Gaast, BWG (Bas) van Rhijn, T Catsburg - Wittebol, C Schmidt, GHJ Mickisch

Research output: Contribution to journal › Article › Academic › peer-review

70 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	342-345
Number of pages	4
Journal	Cancer Chemotherapy & Pharmacology
Volume	49
DOIs	https://doi.org/10.1007/s00280-001-0417-z
Publication status	Published - 2002

Research programs

EMC MM-03-49-01
EMC MM-03-86-08

Access to Document

10.1007/s00280-001-0417-z

http://hdl.handle.net/1765/74300

Cite this

@article{d02e38b5e68740018c8a746272a48b45,

title = "A phase II trial of methotrexate-human serum albumine ( MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy",

author = "Vis, {AN (Andr{\'e})} and {van der Gaast}, Ate and {van Rhijn}, {BWG (Bas)} and {Catsburg - Wittebol}, T and C Schmidt and GHJ Mickisch",

year = "2002",

doi = "10.1007/s00280-001-0417-z",

language = "Undefined/Unknown",

volume = "49",

pages = "342--345",

journal = "Cancer Chemotherapy & Pharmacology",

issn = "0344-5704",

publisher = "Springer Science+Business Media",

}

TY - JOUR

T1 - A phase II trial of methotrexate-human serum albumine ( MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy

AU - Vis, AN (André)

AU - van der Gaast, Ate

AU - van Rhijn, BWG (Bas)

AU - Catsburg - Wittebol, T

AU - Schmidt, C

AU - Mickisch, GHJ

PY - 2002

Y1 - 2002

U2 - 10.1007/s00280-001-0417-z

DO - 10.1007/s00280-001-0417-z

M3 - Article

C2 - 11914915

SN - 0344-5704

VL - 49

SP - 342

EP - 345

JO - Cancer Chemotherapy & Pharmacology

JF - Cancer Chemotherapy & Pharmacology

ER -